Medchemexpress LLC S18-000003 | 2068119-11-7 | 99.3% | 10 MG

Supplier:  Medchemexpress LLC HY11936610MG

A potent, selective, orally active inhibitor of the RORγt nuclear receptor for preclinical research into Th17-mediated conditions such as psoriasis. Demonstrates sub-30 nM inhibition of human RORγt, strong selectivity versus related receptors, and documented solubility and storage properties for experimental use.

• Potent and selective RORγt inhibition (IC50 <30 nM).
• Selective over other ROR family members (IC50 >10 μM).
• Orally active, enabling in vivo study applications.
• High purity for reproducible experimental results.
• Solid white to yellow form for straightforward handling.
• High solubility in DMSO (100 mg/mL) for stock preparation.
• Stable as powder at -20°C for long-term storage.

Catalog No. 50-002-34146